Literature DB >> 10488739

Identification of a natural soluble form of human CD5.

J Calvo1, L Places, G Espinosa, O Padilla, J M Vilà, N Villamor, M Ingelmo, T Gallart, J Vives, J Font, F Lozano.   

Abstract

CD5 is a 67 kDa type I glycoprotein which belongs to the Scavenger Receptor Cysteine-Rich (SRCR) family of receptors. This family includes either cell-surface (e.g. CD6) or secreted (e.g. Spalpha) proteins implicated in the development of the immune system and the regulation of immune responses. In this study, we purified and characterised a circulating natural soluble CD5 form (nsCD5) which is indistinguishable (in apparent molecular mass, glycosylation pattern, and antibody reactivity) from a recombinant soluble CD5 form (rsCD5) composed of the three extracellular SCRC domains. The nsCD5 is a N-glycosylated 52 kDa molecule present in normal human serum and in supernatants of in vitro phorbol ester- and CD3-stimulated peripheral blood mononuclear cells. The nsCD5 concentration in sera from healthy donors is relatively low (median 1.75 ng/ml, rn=166) and is similar to that found in sera from patients suffering of various autoimmune (systemic lupus erythematosus, primary Sjogren syndrome, rheumatoid arthritis) and non-autoimmune (chronic renal failure, B-cell chronic lymphocytic leukemia) disorders. In vitro experiments indicate that nsCD5 is released by proteolytic cleavage of the membrane form. These results represent the first evidence of proteolytic release of a transmembrane SRCR family member following cell activation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10488739     DOI: 10.1034/j.1399-0039.1999.540203.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  12 in total

Review 1.  The immunomodulatory properties of the CD5 lymphocyte receptor in health and disease.

Authors:  Gloria Soldevila; Chander Raman; Francisco Lozano
Journal:  Curr Opin Immunol       Date:  2011-04-07       Impact factor: 7.486

2.  Surface Plasmon Resonance Immunosensor with Antibody-Functionalized Magnetoplasmonic Nanoparticles for Ultrasensitive Quantification of the CD5 Biomarker.

Authors:  Asta Kausaite-Minkstimiene; Anton Popov; Almira Ramanaviciene
Journal:  ACS Appl Mater Interfaces       Date:  2022-05-02       Impact factor: 10.383

3.  The CD5 ectodomain interacts with conserved fungal cell wall components and protects from zymosan-induced septic shock-like syndrome.

Authors:  Jorge Vera; Rafael Fenutría; Olga Cañadas; Maite Figueras; Rubén Mota; Maria-Rosa Sarrias; David L Williams; Cristina Casals; José Yelamos; Francisco Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-13       Impact factor: 11.205

4.  The Lymphocytic Scavenger Receptor CD5 Shows Therapeutic Potential in Mouse Models of Fungal Infection.

Authors:  María Velasco-de Andrés; Cristina Català; Sergi Casadó-Llombart; Mario Martínez-Florensa; Inês Simões; Joaquín García-Luna; Gustavo Mourglia-Ettlin; Óscar Zaragoza; Esther Carreras; Francisco Lozano
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

5.  CD6 binds to pathogen-associated molecular patterns and protects from LPS-induced septic shock.

Authors:  Maria-Rosa Sarrias; Montserrat Farnós; Rubén Mota; Fernando Sánchez-Barbero; Anna Ibáñez; Idoia Gimferrer; Jorge Vera; Rafael Fenutría; Cristina Casals; José Yélamos; Francisco Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-29       Impact factor: 11.205

6.  Transgenic expression of soluble human CD5 enhances experimentally-induced autoimmune and anti-tumoral immune responses.

Authors:  Rafael Fenutría; Vanesa G Martinez; Inês Simões; Jorge Postigo; Victor Gil; Mario Martínez-Florensa; Jordi Sintes; Rodrigo Naves; Kevin S Cashman; José Alberola-Ila; Manel Ramos-Casals; Gloria Soldevila; Chander Raman; Jesús Merino; Ramón Merino; Pablo Engel; Francisco Lozano
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

7.  Immunomodulatory effects of soluble CD5 on experimental tumor models.

Authors:  Inês T Simões; Fernando Aranda; Esther Carreras; Maria Velasco-de Andrés; Sergi Casadó-Llombart; Vanesa G Martinez; Francisco Lozano
Journal:  Oncotarget       Date:  2017-11-20

8.  Human CD6 Down-Modulation following T-Cell Activation Compromises Lymphocyte Survival and Proliferative Responses.

Authors:  Esther Carrasco; Cristina Escoda-Ferran; Núria Climent; Cristina Miró-Julià; Inês T Simões; Mario Martínez-Florensa; Adelaida Sarukhan; Esther Carreras; Francisco Lozano
Journal:  Front Immunol       Date:  2017-06-30       Impact factor: 7.561

Review 9.  SheddomeDB: the ectodomain shedding database for membrane-bound shed markers.

Authors:  Wei-Sheng Tien; Jun-Hong Chen; Kun-Pin Wu
Journal:  BMC Bioinformatics       Date:  2017-03-14       Impact factor: 3.169

Review 10.  Soluble CD5 and CD6: Lymphocytic Class I Scavenger Receptors as Immunotherapeutic Agents.

Authors:  María Velasco-de Andrés; Sergi Casadó-Llombart; Cristina Català; Alejandra Leyton-Pereira; Francisco Lozano; Fernando Aranda
Journal:  Cells       Date:  2020-12-03       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.